247 related articles for article (PubMed ID: 22226482)
1. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
Ola MS; Nawaz MI; Siddiquei MM; Al-Amro S; Abu El-Asrar AM
J Diabetes Complications; 2012; 26(1):56-64. PubMed ID: 22226482
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in understanding the biochemical and molecular mechanism of diabetic cardiomyopathy.
Liu JW; Liu D; Cui KZ; Xu Y; Li YB; Sun YM; Su Y
Biochem Biophys Res Commun; 2012 Oct; 427(3):441-3. PubMed ID: 22995317
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
Wan TT; Li XF; Sun YM; Li YB; Su Y
Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
[TBL] [Abstract][Full Text] [Related]
4. Diabetic retinopathy--biomolecules and multiple pathophysiology.
Ahsan H
Diabetes Metab Syndr; 2015; 9(1):51-4. PubMed ID: 25450817
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.
Sun YM; Su Y; Li J; Wang LF
Biochem Biophys Res Commun; 2013 Apr; 433(4):359-61. PubMed ID: 23541575
[TBL] [Abstract][Full Text] [Related]
6. Advances in biochemical mechanisms of diabetic retinopathy.
Giusti C; Gargiulo P
Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
[TBL] [Abstract][Full Text] [Related]
7. [Biochemical mechanisms in the pathogeny of diabetic retinopathy].
Zamfir C
Oftalmologia; 2009; 53(2):8-12. PubMed ID: 19697833
[TBL] [Abstract][Full Text] [Related]
8. Implication of oxidative stress in progression of diabetic retinopathy.
Behl T; Kaur I; Kotwani A
Surv Ophthalmol; 2016; 61(2):187-96. PubMed ID: 26074354
[TBL] [Abstract][Full Text] [Related]
9. Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy.
Satari M; Aghadavod E; Mobini M; Asemi Z
J Cell Physiol; 2019 Jun; 234(6):8522-8532. PubMed ID: 30478922
[TBL] [Abstract][Full Text] [Related]
10. The RAGE axis in early diabetic retinopathy.
Barile GR; Pachydaki SI; Tari SR; Lee SE; Donmoyer CM; Ma W; Rong LL; Buciarelli LG; Wendt T; Hörig H; Hudson BI; Qu W; Weinberg AD; Yan SF; Schmidt AM
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2916-24. PubMed ID: 16043866
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein kinase C might be harmful to diabetic retinopathy.
Yamagishi S; Takeuchi M
Med Hypotheses; 2004; 63(1):135-7. PubMed ID: 15193366
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
Kanwar M; Chan PS; Kern TS; Kowluru RA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia and oxidative stress in the causation of diabetic retinopathy.
Arden GB; Sivaprasad S
Curr Diabetes Rev; 2011 Sep; 7(5):291-304. PubMed ID: 21916837
[TBL] [Abstract][Full Text] [Related]
14. Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy.
Parveen A; Kim JH; Oh BG; Subedi L; Khan Z; Kim SY
Molecules; 2018 Jun; 23(7):. PubMed ID: 29937497
[No Abstract] [Full Text] [Related]
15. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
Friedman EA
Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
[TBL] [Abstract][Full Text] [Related]
16. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
Li L; Renier G
Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
[TBL] [Abstract][Full Text] [Related]
17. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Hammes HP; Du X; Edelstein D; Taguchi T; Matsumura T; Ju Q; Lin J; Bierhaus A; Nawroth P; Hannak D; Neumaier M; Bergfeld R; Giardino I; Brownlee M
Nat Med; 2003 Mar; 9(3):294-9. PubMed ID: 12592403
[TBL] [Abstract][Full Text] [Related]
18. Treating diabetic retinopathy by tackling growth factor pathways.
Chiarelli F; Giannini C; Di Marzio D; Mohn A
Curr Opin Investig Drugs; 2005 Apr; 6(4):395-409. PubMed ID: 15898347
[TBL] [Abstract][Full Text] [Related]
19. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
[TBL] [Abstract][Full Text] [Related]
20. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M
Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
